Stratifying patients suitable for ICD in heart failure

Basit Iqbal, Geoffrey Currie, Janelle Wheat, Herbert Jelinek, Hosen Kiat

Research output: Other contribution to conferenceAbstractpeer-review


Heart failure (HF) is a frequently encounter condition in the pharmacy that requires treatment to be individualised depending on the presenting symptoms. Chronic heart failure (CHF) involves both mechanical failure and autonomic nervous system dysfunction which can lead to sudden cardiac death (SCD). A number of therapies are utilised including pharmaceutical and device options; for example the implantable cardioverter/defibrillator (ICD) device. A decision to use an ICD is based on CHF patients presenting with a New York Heart Association (NYHA) classification of IIor III and a left ventricular ejection fraction (LVEF) less than or equal to 35%. A large percentage of ICD devices, however, never deliver therapy during their lifetime while as many as 33% of patients ineligible for an ICD (LVEF > 35%) die of SCD.
Original languageEnglish
Number of pages1
Publication statusPublished - Sept 2012


Dive into the research topics of 'Stratifying patients suitable for ICD in heart failure'. Together they form a unique fingerprint.

Cite this